Evidence map›Paper›PMID 29104911›Full record

ArticleChemistrySelect2017

Facile Synthesis of a Next Generation Safety-Catch Acid-Labile Linker, SCAL-2, Suitable for Solid-Phase Synthesis, On-Support Display and for Post-Synthesis Tagging.

Christophe Portal, Martin Hintersteiner, Olivier Barbeau, Peter Dodd, Margaret Huggett, Irene Pérez-Pi, David Evans, Manfred Auer

Abstract read
In one paragraph

Article in ChemistrySelect, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Safety-Catch Linkers for Solid-Phase Peptide Synthesis.Molecules (Basel, Switzerland) · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christophe PortalEdinburgh BioQuarter 9 Little France Road, Edinburgh Scotland EH16 4UX U.K.
Martin HintersteinerSchool of Biological Sciences and Edinburgh Medical School: Biomedical Sciences University of Edinburgh, The King's Buildings, Edinburgh Scotland EH9 3BF U.K.
Olivier BarbeauSchool of Biological Sciences and Edinburgh Medical School: Biomedical Sciences University of Edinburgh, The King's Buildings, Edinburgh Scotland EH9 3BF U.K.
Peter DoddSchool of Biological Sciences and Edinburgh Medical School: Biomedical Sciences University of Edinburgh, The King's Buildings, Edinburgh Scotland EH9 3BF U.K.
Margaret HuggettSchool of Biological Sciences and Edinburgh Medical School: Biomedical Sciences University of Edinburgh, The King's Buildings, Edinburgh Scotland EH9 3BF U.K.
Irene Pérez-PiSchool of Biological Sciences and Edinburgh Medical School: Biomedical Sciences University of Edinburgh, The King's Buildings, Edinburgh Scotland EH9 3BF U.K.
David EvansSchool of Biological Sciences and Edinburgh Medical School: Biomedical Sciences University of Edinburgh, The King's Buildings, Edinburgh Scotland EH9 3BF U.K.
Manfred AuerSchool of Biological Sciences and Edinburgh Medical School: Biomedical Sciences University of Edinburgh, The King's Buildings, Edinburgh Scotland EH9 3BF U.K.ORCID 0000-0001-8920-3522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SCAL linker, a safety catch linker, is amongst the most versatile linkers for solid phase synthesis. It was originally described in 1991 by Pátek and Lebl. Yet, its application has been hindered by the low yields of published synthetic routes. Over time, the exceptional versatility of this linker has been demonstrated in several applications of advanced solid phase synthesis of peptides and peptidomimetics. Recently, an updated synthesis of the original linker has also been presented at the 22

Indexed as

on-bead screeningOne-bead one-compoundSafety catch linkerSCAL linkersolid phase synthesis

Identifiers

PMID29104911
PMCPMC5661701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.